M&A activity in the general healthcare sector has yet to rebound from COVID-19. However, while overall deal numbers remain below pre-pandemic historical averages, deal size has increased. … [Read more...]
M&A Report
PerkinElmer Acquires BioLegend While FTC Warns Against Non-Approved Mergers
October 5, 2021
DX Deals: Twist Bioscience Unveils 3 New Strategic Collaborations for Synthetic Biology Discovery
October 1, 2021
High-quality synthetic DNA powers molecular research and the discovery and development of innovative new diagnostic products. Twist Bioscience has developed a proprietary process featuring a … [Read more...]
M&A Report
Illumina Makes Audacious Move by Completing Grail Acquisition Without Regulatory Approval
September 13, 2021
It’s damn the torpedoes and full speed ahead for Illumina. Recognizing that it had no chance of securing the necessary regulatory approval in time to make the hard closing deadline and staring a $300 … [Read more...]
DX Deals
Labcorp Teams with Oncology Research Startup to Eliminate Demographic Disparities in Cancer Treatment
September 13, 2021
Studies show that demographic differences can impact cancer care and that disadvantaged populations suffer from a lack of access to advanced precision cancer diagnostics and treatments. Evaluating and … [Read more...]
DX Deals
Amazon Already Making a Mark on Direct-to-Consumer COVID-19 Test Market
August 26, 2021
Will Amazon transform diagnostic lab testing the way it did the retail industry? Probably not. But the tech giant with the proven capacity to reach into the home and change the shopping patterns of … [Read more...]
M&A Report
Biden Orders Feds to Target Health Care Consolidation but Deals Continue
August 26, 2021
This month’s big stories in M&A deal making come not just from the market but the regulatory front. New Biden Executive Order Targets Health Care Consolidation Consolidation in the health … [Read more...]
M&A Report
Biden Orders Feds to Target Health Care Consolidation but Deals Continue
August 16, 2021
This month’s big stories in M&A deal making come not just from the market but the regulatory front. New Biden Executive Order Targets Health Care Consolidation Consolidation in the health … [Read more...]
DX Deals
Cloud-Based Platform Enlists Quest to Provide COVID-19 Molecular Test Results to Travelers
August 16, 2021
As proof of COVID-19 vaccination and/or negative molecular test results morphs into a passport for air travel and attending live events, labs with the capacity to generate rapid and reliable tests and … [Read more...]
DX Deals
Amazon Already Making a Mark on Direct-to-Consumer COVID-19 Test Market
July 11, 2021
Will Amazon transform diagnostic lab testing the way it did the retail industry? Probably not. But the tech giant with the proven capacity to reach into the home and change the shopping patterns of … [Read more...]
M&A Report
23andMe Goes Public While the Clock Ticks on Illumina’s Grail Acquisition
July 11, 2021
M&A deal making in the diagnostics space remained hot and heavy in June. Key deals included Danaher’s announced $9.6 billion acquisition of life sciences plasma DNA maker Aldevron and the closing … [Read more...]
